{"nct_id":"NCT01235975","title":"Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 Years","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2010-11-30","start_date_type":"ACTUAL","primary_completion_date":"2011-07-29","primary_completion_date_type":"ACTUAL","completion_date":"2011-08-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}